| John A. Bencich |
John A. Bencich is currently the Director, Chief Executive & Financial Officer at Achieve Life Sciences, Inc. He previously worked as the Finance Director & Controller at Onyx Software Corp. from 2004 to 2007. Prior to that, he was the General Manager at Ernst & Young LLP from 1999 to 2004. From 2007 to 2010, he served as the Chief Financial Officer, Treasurer & VP at Emergent Product Development Seattle. In 2011, he was the Chief Financial Officer at Allozyne, Inc. From 2012 to 2014, he held the position of Chief Financial Officer at Integrated Diagnostics, Inc. Lastly, from 2014 to 2017, he worked as the Chief Financial Officer & Vice President at OncoGenex Pharmaceuticals, Inc. Mr. Bencich obtained an MBA from Seattle University in 2011 and an undergraduate degree from the University of San Diego in 1999. |
| Jerry Wan |
Jerry Wan is currently working as the Chief Accounting Officer at Achieve Life Sciences, Inc. He started this position in 2020. Prior to his current role, Jerry worked as the Director-Accounting Operations at OncoGenex Pharmaceuticals, Inc. from 2014 to 2017. Before that, he was the Manager-Management Reporting at Gateway Casinos & Entertainment Ltd. from 2010 to 2011. Jerry completed his undergraduate degree at the University of British Columbia. |
| Anthony John Clarke |
Anthony John Clarke is the founder of Ricanto Ltd. (founded in 2009) and holds the title of Director. He is currently the Vice President-Clinical Development at Amarin Neuroscience Ltd. (since 2005), the Chief Scientific Officer at Renown Pharmaceuticals Pvt Ltd. (since 2016), and the Chief Scientific Officer at Achieve Life Sciences, Inc. (since 2015). In the past, he held positions such as Senior Director-Clinical & Regulatory Affairs at Cephalon, Inc. (2000-2004), Director-Clinical Development at Curidium Medica Ltd. (2004-2005), and VP-Clinical Research & Regulatory Affairs at Amarin Corp. Plc (2005-2008). He also served as the VP-International Development Operations at Alexza Pharmaceuticals, Inc. (2008-2009) and as the Head-CNS, Cardiovascular & Respiratory Research at GSK Plc. Additionally, he was the Chief Scientific Officer at Huxley Pharmaceuticals, Inc. and Vice President-Products at Aihit Ltd. He has a background in undergraduate studies from the University of Sunderland and holds a doctorate degree from the University of London. |
| Richard Alistair Balfour Stewart |
Richard Alistair Balfour Stewart was the founder of SkyePharma Plc (founded in 1995) where he held the title of Chief Financial & Business Officer from 1995 to 1998. He was also the founder of Amarin Corp. Plc (founded in 2000) where he served as the Chief Executive Officer from 2000 to 2007. Additionally, he founded Zogenix International Ltd. (founded in 2013) and held the position of Chairman & Chief Executive Officer from 2013 to 2014. In 2009, Mr. Stewart founded Ricanto Ltd. and currently serves as a Director. His current job positions include being the Chairman & Chief Executive Officer at Renown Pharmaceuticals Pvt Ltd. since 2016 and the Executive Chairman at Achieve Life Sciences, Inc. since 2015. Mr. Stewart has previously worked as the Chairman & Chief Executive Officer at Huxley Pharmaceuticals, Inc. in 2009. He has also held positions as Chairman at Achieve Life Science, Inc. and Director at Avicena Group, Inc. He completed his undergraduate degree at the University of Bath. |
| Cindy A. Jacobs |
Cindy A. Jacobs is the founder of Eagles Ridge Executive Consulting LLC, founded in 2020. She is currently the Director at Renown Pharmaceuticals Pvt Ltd. since 2018, President, Director & Chief Medical Officer at Achieve Life Sciences, Inc. since 2008, Director at Hibercell, Inc. since 2021, and Director at Pacylex Pharmaceuticals, Inc. since 2020. Previously, she served as the Chief Medical Officer & SVP-Clinical Development at Corixa Corp. from 1999 to 2005, Vice President-Clinical Research at CellPro, Inc., and Chief Medical Officer & Executive Vice President at OncoGenex Technologies, Inc. from 2005 to 2008. She also held the position of Chief Medical Officer & Executive Vice President at OncoGenex Pharmaceuticals, Inc. Dr. Jacobs completed her undergraduate degree at Montana State University in 1979, her doctorate degree at Washington State University in 1984, and her graduate degree at Washington University School of Medicine in 1989. |
| Thomas Sellig |
Thomas Sellig is currently the Chief Executive Officer at Adare Pharma Solutions, Inc. He is also an Independent Director at Achieve Life Sciences, Inc. and the Co-Managing Director at Adare Pharmaceuticals SAS. Previously, he held the position of Global Vice President-Sales & Client Services at Labcorp Drug Development, Inc. and Chief Commercial Officer at PSKW LLC. |
| Bridget A. Martell |
Bridget A. Martell is the founder of Bam Consultants Ltd. She currently holds multiple positions including President & Chief Executive Officer at Artizan Biosciences, Inc., Independent Director at Achieve Life Sciences, Inc., Independent Director at Aligos Therapeutics, Inc., Director at Ayala Pharmaceuticals, Inc., and Director at Delcath Systems, Inc. In her former roles, Dr. Martell served as Executive Director & Head-Medical Affairs at Purdue Pharma LP from 2011 to 2013, Medical Director at Albert Einstein College of Medicine, Inc. from 2001 to 2003, Independent Director at POINT Biopharma Global, Inc. in 2023, Chief Medical Officer at Catalent JNP, Inc. from 2015 to 2017, Chief Medical Officer at Kura Oncology, Inc. in 2020, Chief Medical Officer at RRD International LLC from 2018 to 2020, and Chief Medical Officer at Verseau Therapeutics, Inc. from 2020 to 2021. She also holds the position of Clinical Professor at Yale School of Medicine. Dr. Martell obtained her graduate degree from Boston University, her undergraduate degree from Cornell University, and her doctorate from Chicago Medical School. |
| Vaughn B. Himes |
Vaughn B. Himes is an Independent Director at VBI Vaccines, Inc. since 2023 and at Achieve Life Sciences, Inc. since 2022. Previously, he held positions such as Associate Director-Biological Development at Wyeth Lederle Vaccines SA, Director at Seagen International GmbH from 2015 to 2021, Vice President-Manufacturing Operations at AmpliPhi Biosciences Corp. from 2000 to 2003, Vice President-Worldwide Manufacturing at Corixa Corp. from 2003 to 2005, Chief Technical Officer at Seagen Inc. from 2009 to 2023, Senior Vice President-Technical Operations at ZymoGenetics, Inc. from 2005 to 2009, and Vice President-Product Development at Genovo, Inc. from 1999 to 2000. He obtained his undergraduate degree from Pomona College and his doctorate from the University of Minnesota. |
| Stuart Duty |
Stuart Duty is an Independent Director at EyePoint Pharmaceuticals, Inc. and Achieve Life Sciences, Inc. He previously worked as a Senior Managing Director at Guggenheim Partners LLC from 2012 to 2023. Before that, he was a Managing Director at Piper Jaffray, Inc. from 1992 to 2002. Stuart also served as the Chief Operating Officer at Oracle Partners LP from 2002 to 2007. He holds an undergraduate degree from Occidental College and an MBA from Harvard Business School. |
| Thomas Braxton King |
Thomas Braxton King is currently the Executive Chairman at Concentric Analgesics, Inc., Chairman at Kinaset Therapeutics, Inc., Director at Faraday Pharmaceuticals, Inc., Independent Director at Achieve Life Sciences, Inc., and Independent Director at TFF Pharmaceuticals, Inc. Previously, he served as the President, Chief Executive Officer & Director at Anesta Corp., President, Chief Executive Officer, CFO & CAO at Alexza Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Cognetix, Inc., Director at Orphan Medical, Inc., Independent Director at VIVUS, Inc., Director at Achaogen, Inc., Director at Faraday Pharmaceuticals, Inc. (Washington), Director at Symphony Allegro, Inc., and Independent Director at Satsuma Pharmaceuticals, Inc. He obtained his undergraduate degree from McPherson College in 1977 and his MBA from Kansas University School of Business. |
